Probaclac GI
Natural health product licensed in Canada
- Licence holder
- Les laboratoires Nicar inc.
- NPN or DIN-HM
- 80083663
- Status
- Active licence
- Licence date
- 7 March 2018
- Revision date
- 15 November 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lacticaseibacillus rhamnosus Source : A008 | 300 % | Not calculated |
| Lacticaseibacillus rhamnosus Source : Cellule entière | 300 % | Not calculated |
| Bifidobacterium longum subsp. longum Source : A027 | 300 % | Not calculated |
| Bifidobacterium longum subsp. longum Source : Cellule entière | 300 % | Not calculated |
| Lacticaseibacillus rhamnosus Source : A008 | 10 Milliards d'UFC | Not calculated |
| Lacticaseibacillus rhamnosus Source : Cellule entière | 10 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : A027 | 2 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : Cellule entière | 2 Milliards d'UFC | Not calculated |
| Bifidobacterium breve Source : A006 | 300 % | Not calculated |
| Bifidobacterium breve Source : Cellule entière | 300 % | Not calculated |
| Bifidobacterium breve Source : A006 | 600 Millions d'UFC | Not calculated |
| Bifidobacterium breve Source : Cellule entière | 600 Millions d'UFC | Not calculated |
| Bifidobacterium bifidum Source : Cellule entière | 300 % | Not calculated |
| Bifidobacterium bifidum Source : A058 | 300 % | Not calculated |
| Lacticaseibacillus paracasei Source : Cellule entière | 300 % | Not calculated |
| Lacticaseibacillus paracasei Source : A179 | 300 % | Not calculated |
| Bifidobacterium bifidum Source : Cellule entière | 400 Millions d'UFC | Not calculated |
| Bifidobacterium bifidum Source : A058 | 400 Millions d'UFC | Not calculated |
| Lacticaseibacillus paracasei Source : Cellule entière | 2 Milliards d'UFC | Not calculated |
| Lacticaseibacillus paracasei Source : A179 | 2 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Maltodextrine, Dioxyde de titane, Acide ascorbique, Hypromellose, Inuline, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 12 years | minimum: 1 Capsule ; maximum: 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Aide à contrôler la diarrhée infectieuse aiguë. Aide à contrôler et/ou à réduire le risque d'être atteint d'une diarrhée associée à la prise d'antibiotiques. Contribue à soutenir la santé intestinale/gastrointestinale.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Ne pas utiliser si le sceau de sécurité est brisé ou manquant.
- Contre-indications
Si vous souffrez d'un déficit immunitaire (p. ex. sida, lymphome, patients subissant un traitement prolongé aux corticostéroïdes), ne pas utiliser ce produit.
- Précautions et mises en garde
Si vous souffrez de fièvre, de vomissements, de diarrhée sanglante ou de douleurs abdominales intenses, consulter un praticien de soins de santé avant d'en faire l'usage. Si des symptômes de troubles digestifs (p. ex. diarrhée) se manifestent, s'aggravent et/ou persistent au-delà de 3 jours, cesser l'utilisation et consulter un praticien de soins de santé.
Source
Official Health Canada record, licence 80083663
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging